Research Article
The Effect of Histological CD20-Positive B Cell Infiltration in Acute Cellular Rejection on Kidney Transplant Allograft Survival
Table 2
Patient baseline characteristics stratified by CD20 staining.
| Characteristics | CD20-negative () | CD20-positive () | value |
| Sex (male/female) | 54/29 | 94/39 | 0.387 | Age at transplantation (years) | | | 0.332 | Warm ischemia time (min) | | | 0.657 | Cold ischemia time (min) | | | 0.792 | Donor type | | | 0.863 | Living | 17 (20.5%) | 26 (19.5%) | | Deceased | 66 (79.5%) | 107 (80.1%) | | Primary disease | | | 0.445 | Chronic nephritis | 75 (90.4%) | 119 (89.5%) | | AKPD | 6 (7.2%) | 5 (3.8%) | | Diabetic nephropathy | 0 (0) | 2 (1.5%) | | Gouty nephropathy | 0 (0) | 2 (1.5%) | | Hereditary nephropathy | 0 (0) | 2 (1.5%) | | Others | 2 (2.4%) | 3 (2.2%) | | Number of HLA mismatches | | | 0.468 | Induction regimen | | | 0.498 | CD25 monoclonal antibody | 35 (42.2%) | 46 (34.6%) | | ATG/OKT3 | 4 (4.8%) | 9 (6.8%) | | None | 44 (53.0%) | 78 (58.6%) | | PRA > 10% – number (%) | | | | After transplant | 4 (4.8%) | 2 (1.5%) | 0.149 | At rejection | 3 (3.6%) | 5 (3.8%) | 0.956 | Prerejection immunosuppressant arms | | 0.230 | FK506 + MMF +Pred | 53 (63.9%) | 76 (57.1%) | | CSA + MMF + Pred | 27 (32.5%) | 53 (39.8%) | | Rapamycin + MMF + Pred | 1 (1.2%) | 2 (1.5%) | | CSA + rapamycin + Pred | 2 (2.4%) | 0 | | CSA + AZA + Pred | 0 (0) | 2 (1.5%) | | Median days to ACR (range) (days) | 29 (3–3878) | 142 (3–3398) | 0.016 |
|
|
PRA, panel reactive antibody; AZA, azathioprine; CSA, cyclosporine; FK506, tacrolimus; MMF, mycophenolate mofetil; PRED, prednisone.
|